SCHEMBL1725669

SCHEMBL1725669

CC(C)(C)OC(=O)N1CC(c2ccccc2F)[C@H](N)C1

nearest known ligand 0.49

Predicted protein targets (top 13)

geneUniProtsupporting neighboursconfidence
RORC P51449 1/20 0.49
KDM1A O60341 2/20 0.44
KDM1B Q8NB78 1/20 0.44
NAMPT P43490 1/20 0.42
DPP4 P27487 1/20 0.42
USP30 Q70CQ3 3/20 0.42
TACR1 P25103 2/20 0.41
GPR119 Q8TDV5 2/20 0.41
MEN1 O00255 1/20 0.40
KMT2A Q03164 1/20 0.40
PDE4B Q07343 1/20 0.40
SCN9A Q15858 1/20 0.40
LIPE Q05469 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL148142 1.00 RORC (0.49) RORCKDM1AKDM1BNAMPTDPP4
SCHEMBL148143 1.00 RORC (0.49) RORCKDM1AKDM1BNAMPTDPP4
SCHEMBL148144 1.00 RORC (0.49) RORCKDM1AKDM1BNAMPTDPP4
SCHEMBL528557 0.90 RORC (0.45) RORCNAMPTDPP4USP30GPR119
SCHEMBL527742 0.89 DPP4 (0.45) RORCNAMPTDPP4USP30TACR1
SCHEMBL529014 0.89 GPR119 (0.49) DPP4USP30TACR1GPR119MEN1
SCHEMBL1968429 0.85 DPP4 (0.46) RORCDPP4USP30PDE4B
SCHEMBL527646 0.85 DPP4 (0.53) RORCNAMPTDPP4USP30GPR119
SCHEMBL16780215 0.84 RORC (0.51) RORCNAMPTUSP30TACR1GPR119
SCHEMBL13858400 0.84 RORC (0.51) RORCNAMPTUSP30TACR1GPR119

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2406251-A1 COMPOUNDS FOR THE TREATMENT OF METABOLIC DISORDERS Prosidion Limited (GB) 2012-01-18 EP disclosed
WO-2010103334-A1 COMPOUNDS FOR THE TREATMENT OF METABOLIC DISORDERS PROSIDION LIMITED (GB) 2010-09-16 WO disclosed